WO2009012908A3 - Arzneimittel zur transdermalen anwendung bei tieren - Google Patents

Arzneimittel zur transdermalen anwendung bei tieren Download PDF

Info

Publication number
WO2009012908A3
WO2009012908A3 PCT/EP2008/005747 EP2008005747W WO2009012908A3 WO 2009012908 A3 WO2009012908 A3 WO 2009012908A3 EP 2008005747 W EP2008005747 W EP 2008005747W WO 2009012908 A3 WO2009012908 A3 WO 2009012908A3
Authority
WO
WIPO (PCT)
Prior art keywords
animals
medicament
transdermal use
transdermal
fur
Prior art date
Application number
PCT/EP2008/005747
Other languages
English (en)
French (fr)
Other versions
WO2009012908A2 (de
Inventor
Birgitta Pausch
Dirk Mertin
Christel Mueller-Goymann
Original Assignee
Bayer Animal Health Gmbh
Birgitta Pausch
Dirk Mertin
Christel Mueller-Goymann
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Animal Health Gmbh, Birgitta Pausch, Dirk Mertin, Christel Mueller-Goymann filed Critical Bayer Animal Health Gmbh
Priority to BRPI0814588-1A2A priority Critical patent/BRPI0814588A2/pt
Priority to US12/670,428 priority patent/US20100197791A1/en
Priority to CA2694386A priority patent/CA2694386A1/en
Priority to EP08773993A priority patent/EP2182921A2/de
Priority to AU2008280501A priority patent/AU2008280501A1/en
Priority to JP2010517293A priority patent/JP2010534624A/ja
Publication of WO2009012908A2 publication Critical patent/WO2009012908A2/de
Publication of WO2009012908A3 publication Critical patent/WO2009012908A3/de
Priority to ZA2010/00514A priority patent/ZA201000514B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A61K9/0017—Non-human animal skin, e.g. pour-on, spot-on
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dispersion Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Die Erfindung betrifft pharmazeutische Zubereitungen zur Anwendung am Tier, welche auf das Fell oder die Haut des Tieres appliziert und deren Wirkstoff anschließend transdermal resorbiert wird.
PCT/EP2008/005747 2007-07-26 2008-07-15 Arzneimittel zur transdermalen anwendung bei tieren WO2009012908A2 (de)

Priority Applications (7)

Application Number Priority Date Filing Date Title
BRPI0814588-1A2A BRPI0814588A2 (pt) 2007-07-26 2008-07-15 Produtos farmacêuticos para uso transdérmico em animais
US12/670,428 US20100197791A1 (en) 2007-07-26 2008-07-15 Pharmaceuticals for transdermal use on animals
CA2694386A CA2694386A1 (en) 2007-07-26 2008-07-15 Medicament for transdermal use on animals
EP08773993A EP2182921A2 (de) 2007-07-26 2008-07-15 Arzneimittel zur transdermalen anwendung bei tieren
AU2008280501A AU2008280501A1 (en) 2007-07-26 2008-07-15 Medicament for transdermal use on animals
JP2010517293A JP2010534624A (ja) 2007-07-26 2008-07-15 動物への経皮使用のための医薬
ZA2010/00514A ZA201000514B (en) 2007-07-26 2010-01-22 Medicament for transdermal use on animals

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102007034976.0 2007-07-26
DE102007034976A DE102007034976A1 (de) 2007-07-26 2007-07-26 Arzneimittel zur transdermalen Anwendung bei Tieren

Publications (2)

Publication Number Publication Date
WO2009012908A2 WO2009012908A2 (de) 2009-01-29
WO2009012908A3 true WO2009012908A3 (de) 2009-06-11

Family

ID=40157239

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2008/005747 WO2009012908A2 (de) 2007-07-26 2008-07-15 Arzneimittel zur transdermalen anwendung bei tieren

Country Status (14)

Country Link
US (1) US20100197791A1 (de)
EP (1) EP2182921A2 (de)
JP (1) JP2010534624A (de)
AR (1) AR067561A1 (de)
AU (1) AU2008280501A1 (de)
BR (1) BRPI0814588A2 (de)
CA (1) CA2694386A1 (de)
CL (1) CL2008002077A1 (de)
DE (1) DE102007034976A1 (de)
PE (1) PE20090797A1 (de)
TW (1) TW200922622A (de)
UY (1) UY31227A1 (de)
WO (1) WO2009012908A2 (de)
ZA (1) ZA201000514B (de)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0803254A1 (de) * 1996-04-25 1997-10-29 LUITPOLD PHARMA GmbH Acetylsalicylsäure enthaltende alkoholische Lösungen zur perkutanen Anwendung, deren Verwendung zur antithrombotischen Therapie sowie Arzneimittel
WO1999022716A1 (en) * 1997-11-05 1999-05-14 Nexmed Holdings, Inc. Topical compositions for nsai drug delivery
EP1044684A2 (de) * 1999-04-13 2000-10-18 Nitto Denko Corporation Perkutan absorbierbare Zubereitung
WO2004017998A2 (en) * 2002-08-22 2004-03-04 Novartis Consumer Health S.A. Topical emulsion- gel composition comprising diclofenac sodium
WO2004047795A2 (de) * 2002-11-28 2004-06-10 Bayer Healthcare Ag Dermale applikation von flupirtin

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5855411A (ja) 1981-09-28 1983-04-01 Nitto Electric Ind Co Ltd 基剤組成物および外用医薬組成物
DE69021511T2 (de) 1989-11-14 1996-11-21 Beta Pharm Co Entzündungshemmende Arzneimittel zur äusserlichen Anwendung.
US5093133A (en) 1990-01-24 1992-03-03 Mcneil-Ppc, Inc. Method for percutaneous delivery of ibuprofen using hydroalcoholic gel
TW206152B (de) 1991-03-20 1993-05-21 Kuko Seiyaku Kk
WO1994009777A1 (en) 1992-10-30 1994-05-11 Syntex (U.S.A.) Inc. Transdermal delivery of ketorolac
IT1291362B1 (it) 1997-05-13 1999-01-07 Vectorpharma Int Composizioni farmaceutiche multicomponente bifasiche contenenti sostanze atte a modificare la partizione dei principi attivi
DE10025558A1 (de) 2000-05-24 2001-11-29 Merck Patent Gmbh Topische Zusammensetzung, enthaltend mindestens ein Aryloxim, und Verfahren zu ihrer Herstellung
BR0210104A (pt) 2001-05-31 2004-06-08 Pharmacia Corp Composição inibidora seletiva de ciclooxigenase-2 permeável à pele
JP2003095983A (ja) 2001-09-21 2003-04-03 Lion Corp 皮膚外用剤組成物
US8907153B2 (en) 2004-06-07 2014-12-09 Nuvo Research Inc. Adhesive peel-forming formulations for dermal delivery of drugs and methods of using the same

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0803254A1 (de) * 1996-04-25 1997-10-29 LUITPOLD PHARMA GmbH Acetylsalicylsäure enthaltende alkoholische Lösungen zur perkutanen Anwendung, deren Verwendung zur antithrombotischen Therapie sowie Arzneimittel
WO1999022716A1 (en) * 1997-11-05 1999-05-14 Nexmed Holdings, Inc. Topical compositions for nsai drug delivery
EP1044684A2 (de) * 1999-04-13 2000-10-18 Nitto Denko Corporation Perkutan absorbierbare Zubereitung
WO2004017998A2 (en) * 2002-08-22 2004-03-04 Novartis Consumer Health S.A. Topical emulsion- gel composition comprising diclofenac sodium
WO2004047795A2 (de) * 2002-11-28 2004-06-10 Bayer Healthcare Ag Dermale applikation von flupirtin

Also Published As

Publication number Publication date
TW200922622A (en) 2009-06-01
DE102007034976A1 (de) 2009-01-29
CL2008002077A1 (es) 2009-01-30
UY31227A1 (es) 2009-03-02
US20100197791A1 (en) 2010-08-05
BRPI0814588A2 (pt) 2015-01-20
AU2008280501A1 (en) 2009-01-29
ZA201000514B (en) 2011-04-28
JP2010534624A (ja) 2010-11-11
CA2694386A1 (en) 2009-01-29
WO2009012908A2 (de) 2009-01-29
EP2182921A2 (de) 2010-05-12
PE20090797A1 (es) 2009-07-23
AR067561A1 (es) 2009-10-14

Similar Documents

Publication Publication Date Title
WO2006072589A3 (en) Disubstituted ureas as kinase inhibitors
BRPI0924460A2 (pt) composição farmacêutica para uso em oftalmologia médica e veterinária
BRPI1009860A2 (pt) composto, uso do mesmo, composição farmacêutica e método para tratamento terapêutico ou prevenção de doenças em humanos ou animais
WO2010056922A3 (en) Systems and methods for delivery of biologically active agents
EA021275B9 (ru) Гетероциклические соединения, содержащая их фармацевтическая композиция и их применение для лечения pask-опосредованного заболевания
UY30373A1 (es) Derivados de fenilalanina, procedimientos de preparacion y aplicaciones
DK2451445T3 (da) Fremgangsmåde til at tørre bibw2992, dets salte og faste farmaceutiske formuleringer omfattende denne aktive ingrediens
WO2008087367A3 (fr) Derives de (phenylthiazolyl)-phenyl-propan-1-one et de (phenyloxazodyl)-phenyl-propan-1-one substitues, preparations et utilisations
WO2006081388A3 (en) Substituted pyridazinyl-and pyrimidinyl-quinolin-4-ylamine analogues
WO2008076954A3 (en) Heterocycle compounds and methods of use thereof
CN107406464A8 (zh) 精氨酸酶抑制剂及其治疗用途
WO2009061431A3 (en) Compositions for the treatment and prevention of eyelid swelling comprising an osmotically active ingredient and a vasoconstrictor
WO2013003827A3 (en) Macrogol 15 hydroxystearate formulations
WO2007090661A3 (en) Active substance combination comprising azolylcarbinol compounds
BRPI0909296A2 (pt) uso de pelo menos um princípio ativo, e, composições cosmética, farmacêutica e/ou dermatológica
WO2012119046A3 (en) Heterocyclic compounds for the inhibition of pask
WO2008105507A1 (ja) 脊髄損傷治療薬剤
MX2020001310A (es) Sistema aplicador que contiene una matriz de microagujas con un principio activo para la cicatrizacion.
WO2012094462A3 (en) Heterocyclic compounds for the inhibition of pask
IL284930A (en) History of pyrrolopyrimidines and their use in the treatment of protein kinase-related diseases
BRPI0807867A2 (pt) Derivado de indol ou um sal farmaceuticamente aceitável do mesmo, composição farmacêutica, uso de um derivado de (indol-3-il) heterociclo, e, método de tratamento de dor
WO2011056871A3 (en) Rhamnolipid mechanism
WO2007009686A3 (en) Substituted pyrazoline compounds, their preparation and use as medicaments
WO2007098967A3 (en) Imidazole compounds having pharmaceutical activity towards the sigma receptor
WO2005065713A3 (de) Arzneimittel zur topischen applikation bei tieren

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08773993

Country of ref document: EP

Kind code of ref document: A2

WWE Wipo information: entry into national phase

Ref document number: 2008773993

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: MX/A/2010/000078

Country of ref document: MX

WWE Wipo information: entry into national phase

Ref document number: 2008280501

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 2694386

Country of ref document: CA

Ref document number: 582839

Country of ref document: NZ

WWE Wipo information: entry into national phase

Ref document number: 12670428

Country of ref document: US

WWE Wipo information: entry into national phase

Ref document number: 2010517293

Country of ref document: JP

NENP Non-entry into the national phase

Ref country code: DE

ENP Entry into the national phase

Ref document number: 2008280501

Country of ref document: AU

Date of ref document: 20080715

Kind code of ref document: A

ENP Entry into the national phase

Ref document number: PI0814588

Country of ref document: BR

Kind code of ref document: A2

Effective date: 20100125